Cardiologists against moves to restrict ezetimibe prescribing

Cardiologists have moved to defend the use of the lipid lowering drug ezetimibe in certain patients after a post market review reveals that up to 15% of all patients on the drug could be receiving it outside of PBS restriction criteria. Regulators are now considering recommendations to remove all PBS restrictions on statins while moving ...

Already a member?

Login to keep reading.

© 2021 the limbic